Our team
Meet our team of talented and passionate scientists ready to tackle antimicrobial resistance with us.
-
Adèle James
Co-founder & CTO
-
Alexandros Pantalis
Co-founder & CEO
-
Ilias Theodorou
Research Scientist
-
Julia Burgan
Research Scientist
-
Manon Lemasson
Research Scientist
-
Marine Feyereisen
Research Scientist
-
Natalie Kuljanishvili
Research Assistant
-
Paula Luengo
Laboratory Technician
-
Romain Sausset
Research Scientist
-
Tanya Lilia
Laboratory Technician in the making
-
Adèle James
Co-founder & CTO
-
Alexandros Pantalis
Co-founder & CEO
-
Ilias Theodorou
Research Scientist
-
Julia Burgan
Research Scientist
-
Manon Lemasson
Research Scientist
-
Marine Feyereisen
Research Scientist
-
Natalie Kuljanishvili
Research Assistant
-
Paula Luengo
Laboratory Technician
-
Romain Sausset
Research Scientist
-
Tanya Lilia
Laboratory Technician in the making
Our advisors
-
Daniel de Vos
Research Manager
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, world leader in human phage therapy.
-
Geoffroy Dubus
Partner at Demeter
Major European player in venture capital, private equity and infrastructure for the energy and ecological transition, Demeter manages €1.2bn and has completed 200 investments since its creation in 2005.
-
Pierre Belichard
Founder and CEO of Enterome
Enterome is a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on their unique ability to decode the gut microbiome’s interaction with the immune system. Enterome raised €116M to date.
-
Rob Kniaz
Partner at Hoxton Ventures
Early-stage venture capital firm investing in disruptive tech start-ups throughout Europe, Hoxton Ventures partners with founders seeking to invent new market categories or transform large, existing industries and accelerates their global expansion.
-
Daniel de Vos
Research Manager
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, world leader in human phage therapy.
-
Geoffroy Dubus
Partner at Demeter
Major European player in venture capital, private equity and infrastructure for the energy and ecological transition, Demeter manages €1.2bn and has completed 200 investments since its creation in 2005.
-
Pierre Belichard
Founder and CEO of Enterome
Enterome is a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on their unique ability to decode the gut microbiome’s interaction with the immune system. Enterome raised €116M to date.
-
Rob Kniaz
Partner at Hoxton Ventures
Early-stage venture capital firm investing in disruptive tech start-ups throughout Europe, Hoxton Ventures partners with founders seeking to invent new market categories or transform large, existing industries and accelerates their global expansion.